![](/img/cover-not-exists.png)
[American Thoracic Society American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California - ()] B41. COPD: PHARMACOLOGICAL TREATMENT - Pharmacokinetic (PK) Bioequivalence And Comparable Efficacy/Safety Were Demonstrated With Pearl Therapeutics' Formoterol Fumarate MDI (FF-MDI, PT005) Compared To Foradil® Aerolizer® In A Randomized, Double-Blind, Placebo-Controlled Phase 2b Study In Patients With Moderate To Very-Severe Chronic Obstructive Pulmonary Disease
Rose, Earl St., Strom, Shannon, Fischer, Tracy, Vasilinin, Grygoriy, Golden, Michael, Marier, J F, Reisner, Colin, Orevillo, Chadwick J.Year:
2012
Language:
english
DOI:
10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A2927
File:
PDF, 18 KB
english, 2012